MedTrace Logo

Evolution of Pulsed Oxygen Saturation During Interval Training Compared to Continuous Training in COPD Patients

NCT05825638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2026-01-21

No results posted yet for this study

Summary

A problem often observed during exercise training is oxygen desaturation exclusively during exercise in some patients. In the case of exercise-induced desaturation, it may be suggested to train these patients in interval training to limit exercise-induced desaturation. Interval training consists of alternating active phases of short duration (often 30 seconds to 1 minute) followed by a short active or passive recovery phase of equivalent duration to the previous phase. Investigators therefore hypothesise that interval training on a cycloergometer or treadmill can limit exercise-induced desaturation in COPD patients.

The aim of the study is to observe the evolution of pulsed oxygen saturation between a continuous training session and a interval training session.

Conditions

  • COPD
  • Exercise
  • Pulmonary Rehabilitation
  • Desaturation of Blood

Interventions

OTHER

Interval training session

Interval training consists of a 5-minute warm-up, a 5-minute cool-down and 20 minutes of alternating 60 seconds of high-intensity work (100% of the maximum power recorded in the incremental test that was carried out when the patient was admitted to the pulmonary rehabilitation department) and 60 seconds of unloaded pedalling or rest.

OTHER

Continuous training session

Continuous training consists of a 5 minute warm up, 5 minute cool down and 20 minutes of moderate intensity work. The workload is set at 60% of the patient's maximum power

Sponsors & Collaborators

  • Medrinal Clement

    collaborator UNKNOWN

  • Combret Yann

    collaborator UNKNOWN

  • Machefert Margaux

    collaborator UNKNOWN

  • Groupe Hospitalier du Havre

    lead OTHER

Principal Investigators

  • Guillaume Prieur, PT, PhD · Groupe Hospitalier du Havre

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2025-09-30
Completion
2025-10-10

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05825638 on ClinicalTrials.gov